MASH Masters: Why MASLD and MASH Need to be on Your Radar

8 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are closely linked to cardiometabolic syndrome and type 2 diabetes (T2DM). In this first episode of MASH Masters, Drs Naim Alkhouri and Zobair Younossi will discuss the growing epidemic of MASLD/MASH and the importance of screening for MASLD/MASH in patients with cardiometabolic disease.

Join us for an informative, engaging, and interactive social media event.
- - - - -
Moderator: Naim Alkhouri, MD, FAASLD

Faculty: Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD
- - - - -
Supported by an independent educational grant from Madrigal Pharmaceuticals.

Click the link to view the Accreditation and Disclosure details.
https://img.medscapestatic.com/vim/live/professional_assets/417129-06_social_disclosures_final.pdf
Category
Cardiology
Be the first to comment

Up Next